FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoseph Mekori

Research Profile

Anatomy

Living Beings

Physiology

Chemicals & Drugs

Disorders

Inflammation

Co-author Network

Publications

TOP 3
Yoseph A Mekori; Alon Y Hershko
T cell-mediated modulation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects.
Maamoun Basheer; Lilia Levdansky; Yoseph A Mekori; Herzl Schwalb; Irit Shefler; Raphael Gorodetsky
Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
Irit Shefler; Pazit Salamon; Alon Y Hershko; Yoseph A Mekori
Mast cells as sources and targets of membrane vesicles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoseph Mekori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yoseph A Mekori; Alon Y Hershko
T cell-mediated modulation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects.
Frontiers in immunology 2012;3():6.
2011: Maamoun Basheer; Lilia Levdansky; Yoseph A Mekori; Herzl Schwalb; Irit Shefler; Raphael Gorodetsky
Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
Peptides 2011;32(12):2444-51.
2011: Irit Shefler; Pazit Salamon; Alon Y Hershko; Yoseph A Mekori
Mast cells as sources and targets of membrane vesicles.
Current pharmaceutical design 2011;17(34):3797-804.
2011: Adam Mor; Yoseph A Mekori; Ofer Ben-Moshe; Roni Haklai; Yoel Kloog
Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential Rap1 inhibitor.
The Journal of investigative dermatology 2011;131(10):2040-8.
2011: Adam Mor; Yoseph A Mekori; Ofer Ben-Moshe; Yoel Kloog
Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D(2) and tumor necrosis factor-α release.
Inflammation 2011;34(5):314-8.
2010: Maamoun Basheer; Herzl Schwalb; Maoz Nesher; Dan GILON; Irit Shefler; Yoseph A Mekori; Oz M Shapira; Raphael Gorodetsky
Mast cell activation by fibrinogen-related homologous c-terminal peptides (haptides) modulates systemic blood pressure.
The Journal of allergy and clinical immunology 2010;126(5):1041-8.
2010: Irit Shefler; Pazit Salamon; Tamar Reshef; Adam Mor; Yoseph A Mekori
T cell-induced mast cell activation: a role for microparticles released from activated T cells.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(7):4206-12.
2010: Adaya Weissler; Leor Perl; Yoram Neuman; Yoseph A Mekori; Adam Mor
Neurologic manifestations as presenting symptoms of endocarditis.
The Israel Medical Association journal : IMAJ 2010;12(8):472-6.
2010: Dana Baram; Ornit Dekel; Yoseph A Mekori; Ronit Sagi-Eisenberg
Activation of mast cells by trimeric G protein Gi3; coupling to the A3 adenosine receptor directly and upon T cell contact.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(7):3677-88.
2010: Adam Mor; Irit Shefler; Pazit Salamon; Yoel Kloog; Yoseph A Mekori
Characterization of ERK activation in human mast cells stimulated by contact with T cells.
Inflammation 2010;33(2):119-25.
2010: Leor Perl; Adaya Weissler; Yoseph A Mekori; Adam Mor
Cellular therapy in 2010: focus on autoimmune and cardiac diseases.
The Israel Medical Association journal : IMAJ 2010;12(2):110-5.
2009: Leor Perl; Yoseph A Mekori; Adam Mor
Dropped gallstones mimicking colon cancer.
The Israel Medical Association journal : IMAJ 2009;11(11):697-8.
2009: Elez D Vainer-Mossel; Yoseph A Mekori; Adam Mor
Ischemic stroke in a patient with lupus following influenza vaccination: a questionable association .
The Israel Medical Association journal : IMAJ 2009;11(3):186-7.
2009: Tamar Reshef; Yoseph A Mekori; Adam Mor
Differential antinuclear antibodies pattern.
The Israel Medical Association journal : IMAJ 2009;11(2):123-4.
2008: Adaya Weissler; Yoseph A Mekori; Adam Mor
The role of mast cells in non-allergic inflammation.
The Israel Medical Association journal : IMAJ 2008;10(12):843-5.
2008: Amitai Ziv; Orit Rubin; Avital Moshinsky; Naomi Gafni; Moshe Kotler; Yaron Dagan; Dov Lichtenberg; Yoseph A Mekori; Moshe Mittelman
MOR: a simulation-based assessment centre for evaluating the personal and interpersonal qualities of medical school candidates.
Medical education 2008;42(10):991-8.
2008: Eyal Reinstein; Yoseph A Mekori; Adam Mor
Autoimmunity and mast cell-related diseases.
Expert review of clinical immunology 2008;4(2):267-74.
2008: P Salamon; Nitza G Shoham; Ilaria Puxeddu; Yosef Paitan; Francesca Levi-Schaffer; Yoseph A Mekori
Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance.
The Journal of allergy and clinical immunology 2008;121(2):448-455.e5.
2006: Ido Bachelet; Francesca Levi-Schaffer; Yoseph A Mekori
Mast cells: not only in allergy.
Immunology and allergy clinics of North America 2006;26(3):407-25.
2006: David Tanne; Moti Haim; Uri Goldbourt; Valentina Boyko; Tamar Reshef; Yehuda Adler; Michal Benderly; Yoseph A Mekori; Solomon Behar
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
International journal of cardiology 2006;107(3):322-6.
2006: Marianna Kulka; Nobuyuki Fukuishi; Menachem Rottem; Yoseph A Mekori; Dean D Metcalfe
Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc(epsilon)RI-mediated activation.
Journal of leukocyte biology 2006;79(2):339-50.
2006: Alexander Gerbaulet; Karin Hartmann; Yoseph A Mekori
Mast cell apoptosis.
Methods in molecular biology (Clifton, N.J.) 2006;315():407-23.
2005: P Salamon; Nitza Shoham; Ronit Gavrieli; Baruch Wolach; Yoseph A Mekori
Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells.
Allergy 2005;60(10):1316-9.
2005: Moti Haim; David Tanne; Valentina Boyko; Tamar Reshef; Uri Goldbourt; Alexander Battler; Yoseph A Mekori; Solomon Behar
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
Clinical cardiology 2005;28(1):31-5.
2005: Menachem Rottem; Yoseph A Mekori
Mast cells and autoimmunity.
Autoimmunity reviews 2005;4(1):21-7.
2004: A Brill; Dana Baram; Uri Sela; P Salamon; Yoseph A Mekori; Rami Hershkoviz
Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(11):1725-31.
2004: Yoseph A Mekori
The mastocyte: the "other" inflammatory cell in immunopathogenesis.
The Journal of allergy and clinical immunology 2004;114(1):52-7.
2004: Moti Haim; David Tanne; Alexander Battler; Valentina Boyko; Tamar Reshef; Uri Goldbourt; Daniel Brunner; Yoseph A Mekori; Solomon Behar
Chlamydia pneumoniae and future risk in patients with coronary heart disease.
International journal of cardiology 2004;93(1):25-30.
2003: Karin Hartmann; Barbara Hermes; K Rappersberger; N Sepp; Yoseph A Mekori; Beate M Henz
Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
The British journal of dermatology 2003;149(3):554-9.
2003: Karin Hartmann; Metin Artuc; Stephan E Baldus; Thomas K Zirbes; Barbara Hermes; Juergen Thiele; Yoseph A Mekori; Beate M Henz
Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
The American journal of pathology 2003;163(3):819-26.
2003: David Tanne; Moti Haim; Valentina Boyko; Uri Goldbourt; Tamar Reshef; Yehuda Adler; Daniel Brunner; Yoseph A Mekori; Solomon Behar
Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2003;16(2):166-70.
2002: Yoseph A Mekori; Dana Baram
Heterotypic adhesion-induced mast cell activation: biologic relevance in the inflammatory context.
Molecular immunology 2002;38(16-18):1363-7.
2002: Dana Baram; Ze Peng; Ora Medalia; Yoseph A Mekori; Ronit Sagi-Eisenberg
Synaptotagmin II negatively regulates MHC class II presentation by mast cells.
Molecular immunology 2002;38(16-18):1347-52.
2002: David Tanne; Moti Haim; Valentina Boyko; Uri Goldbourt; Tamar Reshef; Shlomi Matetzky; Yehuda Adler; Yoseph A Mekori; Solomon Behar
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Stroke; a journal of cerebral circulation 2002;33(9):2182-6.
2002: Moti Haim; David Tanne; Valentina Boyko; Tamar Reshef; Uri Goldbourt; Jonathan Leor; Yoseph A Mekori; Solomon Behar
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.
Journal of the American College of Cardiology 2002;39(7):1133-8.
2001: Dana Baram; Gayle G Vaday; P Salamon; I Drucker; Rami Hershkoviz; Yoseph A Mekori
Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(7):4008-16.
2001: Yoseph A Mekori; A M Gilfillan; Cem Akin; K Hartmann; D D Metcalfe
Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL.
Journal of clinical immunology 2001;21(3):171-4.
2001: Dana Baram; Yoseph A Mekori; Ronit Sagi-Eisenberg
Synaptotagmin regulates mast cell functions.
Immunological reviews 2001;179():25-34.
2000: Yoseph A Mekori; Dean D Metcalfe
Mast cells in innate immunity.
Immunological reviews 2000;173():131-40.
1999: SP Bhattacharyya; Yoseph A Mekori; D Hoh; R Paolini; Dean D Metcalfe; PJ Bianchine
Both adhesion to immobilized vitronectin and FcepsilonRI cross-linking cause enhanced focal adhesion kinase phosphorylation in murine mast cells.
Immunology 1999;98(3):357-62.
1999: S Bar-Sela; Tamar Reshef; Yoseph A Mekori
IgE antithyroid microsomal antibodies in a patient with chronic urticaria.
The Journal of allergy and clinical immunology 1999;103(6):1216-7.
1999: Dana Baram; Roberto Adachi; Ora Medalia; Michael J Tuvim; Burton F Dickey; Yoseph A Mekori; Ronit Sagi-Eisenberg
Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells.
The Journal of experimental medicine 1999;189(10):1649-58.
1999: Elizabeth Fireman; Shmuel Kivity; I Shahar; Tamar Reshef; Yoseph A Mekori
Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases.
Immunology letters 1999;67(3):229-36.
1998: Dana Baram; Michal Linial; Yoseph A Mekori; Ronit Sagi-Eisenberg
Ca2+-dependent exocytosis in mast cells is stimulated by the Ca2+ sensor, synaptotagmin I.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(10):5120-3.
1998: Michal Shalita-Chesner; Ruth Koren; Yoseph A Mekori; Dana Baram; Carmela Rotem; Uri A Liberman; Amiram Ravid
1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells.
Molecular and cellular endocrinology 1998;142(1-2):49-55.
1998: N Inamura; Yoseph A Mekori; SP Bhattacharyya; PJ Bianchine; Dean D Metcalfe
Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(8):4026-33.
1998: SP Bhattacharyya; I Drucker; Tamar Reshef; ARNOLD KIRSHENBAUM; Dean D Metcalfe; Yoseph A Mekori
Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact.
Journal of leukocyte biology 1998;63(3):337-41.
1997: E Zeltzer; Jacques Bernheim; Ze'ev Korzets; Mauro Rathaus; Yoseph A Mekori; Rami Hershkoviz
Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(12):2618-22.
1997: Dana Baram; M Rashkovsky; Rami Hershkoviz; I Drucker; Tamar Reshef; S Ben-Shitrit; Yoseph A Mekori
Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation.
Clinical and experimental immunology 1997;110(3):485-91.
1997: Dean D Metcalfe; Dana Baram; Yoseph A Mekori
Mast cells.
Physiological reviews 1997;77(4):1033-79.
1997: Rami Hershkoviz; L Preciado-Patt; Ofer Lider; Mati Fridkin; Jaroslaw Dastych; Dean D Metcalfe; Yoseph A Mekori
Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion.
The American journal of physiology 1997;273(1 Pt 1):C179-87.
1997: Rami Hershkoviz; L Preciado-Patt; Ofer Lider; Mati Fridkin; Yoseph A Mekori
Mast cell adhesion to extracellular matrix: local effects of acute phase reactants.
International archives of allergy and immunology 1997;113(1-3):295-6.
1997: Yoseph A Mekori; C K Oh; Jaroslaw Dastych; Julie P Goff; S Adachi; PJ Bianchine; Alexandra S Worobec; T Semere; JH Pierce; Dean D Metcalfe
Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit.
Immunology 1997;90(4):518-25.
1997: S Finotto; Yoseph A Mekori; Dean D Metcalfe
Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems.
The Journal of clinical investigation 1997;99(7):1721-8.
1995: Francesca Levi-Schaffer; Dana Baram; V Segal; E Garbuzenko; S Lew; Yoseph A Mekori
Prostaglandin E2 production by chronic graft-versus-host disease dermal fibroblasts.
Immunology letters 1995;48(1):11-15.
1995: Rami Hershkoviz; Z Korzets; Mauro Rathaus; D Gilat; I Drucker; Yoseph A Mekori; J Bernheim
Inhibition by uraemic sera of CD4+ T-cell adhesion to extracellular matrix components.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(11):2065-9.
1995: Yoseph A Mekori; C K Oh; Dean D Metcalfe
The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis.
International archives of allergy and immunology 1995;107(1-3):136-8.
1994: D Gilat; Rami Hershkoviz; Yoseph A Mekori; Israel Vlodavsky; Ofer Lider
Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(11):4899-906.
1994: Rami Hershkoviz; Ofer Lider; Dana Baram; Tamar Reshef; Shmuel Miron; Yoseph A Mekori
Inhibition of T cell adhesion to extracellular matrix glycoproteins by histamine: a role for mast cell degranulation products.
Journal of leukocyte biology 1994;56(4):495-501.
1994: Yoseph A Mekori; D D Metcalfe
Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(5):2194-203.
1994: Rami Hershkoviz; N Greenspoon; Yoseph A Mekori; R Hadari; Ronen Alon; G Kapustina; Ofer Lider
Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp.
Clinical and experimental immunology 1994;95(2):270-6.
1993: Yoseph A Mekori; C K Oh; Dean D Metcalfe
IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3775-84.
1993: Rami Hershkoviz; Ronen Alon; Yoseph A Mekori; D Gilat; Liora Cahalon; A Miller; Ofer Lider
Heat-stressed CD4+ T lymphocytes: differential modulations of adhesiveness to extracellular matrix glycoproteins, proliferative responses and tumour necrosis factor-alpha secretion.
Immunology 1993;79(2):241-7.
1993: Yoseph A Mekori; Dana Baram; A Goldberg; R Hershkoviz; Tamar Reshef; D Sredni
Nedocromil sodium inhibits T-cell function in vitro and in vivo.
The Journal of allergy and clinical immunology 1993;91(3):817-24.
1993: Rami Hershkoviz; D Gilat; Shmuel Miron; Yoseph A Mekori; D Aderka; David Wallach; Israel Vlodavsky; Irun R Cohen; Ofer Lider
Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages.
Immunology 1993;78(1):50-7.
1992: Francesca Levi-Schaffer; V Segal; Dana Baram; Yoseph A Mekori
Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts.
The Journal of allergy and clinical immunology 1992;89(2):501-9.
1991: A Goldberg; Z Korzets; J Bernheim; Yoseph A Mekori
Cutaneous responses to histamine, compound 48/80, and codeine in patients with chronic renal failure.
Annals of allergy 1991;67(5):525-8.
1991: A Adunsky; Dana Baram; M Hershkowitz; Yoseph A Mekori
Increased cytosolic free calcium in lymphocytes of Alzheimer patients.
Journal of neuroimmunology 1991;33(2):167-72.
1991: Francesca Levi-Schaffer; V Segal; Yoseph A Mekori; H N Claman; I Hammel
Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes.
Immunology letters 1991;27(1):13-8.
1990: Yoseph A Mekori; Z Zeidan
Mast cells in nonallergic immune responses in vivo.
Israel journal of medical sciences 1990;26(6):337-41.
1990: Francesca Levi-Schaffer; Yoseph A Mekori; V Segal; H N Claman
Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes.
Cellular immunology 1990;127(1):146-58.
1990: Ofer Lider; Yoseph A Mekori; T Miller; R Bar-Tana; Israel Vlodavsky; E Baharav; Irun R Cohen; Yaakov Naparstek
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
European journal of immunology 1990;20(3):493-9.
1990: A Goldberg; M Shapiro; I Hammel; Yoseph A Mekori
Cutaneous responses to histamine, compound 48/80 and codeine in patients with hyperthyroidism.
Annals of allergy 1990;64(2 Pt 1):179-81.
1989: Yoseph A Mekori; D Blickstein; Dana Baram; A Alter; Judith Radnay; LA Rozenszajn; Mordchai Ravid
Characterization of the interference of T cell activation by reserpine.
Cellular immunology 1989;124(2):308-19.
1989: Yoseph A Mekori; Y Chowers; I Ducker; A Klajman
Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line.
Clinical and experimental immunology 1989;78(2):230-2.
1989: Yoseph A Mekori
Mast cell degranulation test: its significance in the diagnosis of drug allergy.
Israel journal of medical sciences 1989;25(10):551-2.
1989: Yoseph A Mekori; Dana Baram; A Goldberg; A Klajman
Inhibition of delayed hypersensitivity reactions in mice by colchicine. I. Mechanism of inhibition of contact sensitivity in vivo.
Cellular immunology 1989;120(2):330-40.
1989: Ofer Lider; E Baharav; Yoseph A Mekori; T Miller; Yaakov Naparstek; Israel Vlodavsky; Irun R Cohen
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.
The Journal of clinical investigation 1989;83(3):752-6.